Houlihan Lokey vs PJT Partners (2026)

PJT Partners is young, small, and deliberately elite. Spun off from Blackstone in 2015, it runs a focused set of businesses: restructuring, M&A and strategic advisory, and Park Hill, its fund placement arm. The Blackstone heritage shows up everywhere, from the institutional polish of the culture to the depth of its relationships with financial sponsors.

Houlihan Lokey is older, bigger, and more diversified. Founded in 1972 and headquartered in Los Angeles, it pairs the world's largest restructuring practice with a corporate finance business in middle-market M&A and a financial advisory services arm doing valuation and transaction opinions. The model is built for all weather: M&A revenue in expansions, restructuring revenue in contractions.

Tier labels capture the difference bluntly. PJT prices itself as an elite boutique and recruits accordingly. HL is the strongest name in the middle market, close enough to the elite tier to compete with it for restructuring talent, but a step behind in brand gravity.

Both firms advise debtors and creditors through distress, and both are fixtures in every major restructuring cycle. The texture differs. HL's practice is the industry's largest, which means volume: more situations, more capital structures, more chances for a junior analyst to run point on a live workstream. PJT concentrates on complex, high-stakes mandates where its senior bench and Blackstone lineage carry weight in the boardroom.

Outside restructuring, the platforms diverge further. PJT's strategic advisory business handles M&A and capital markets advisory for large clients, and Park Hill gives the firm a private funds placement business that HL does not replicate. HL's corporate finance arm executes middle-market M&A across sectors like TMT and healthcare, while its financial advisory services group produces valuations and fairness opinions in steady volume.

Client profile follows the model. PJT skews toward large-cap boards, sponsors, and creditors in marquee situations; HL serves mid-cap companies, creditor groups, and sponsors across a much wider spread of deal sizes.

Neither firm sells balance. Both score 2 out of 5 for work-life balance, and restructuring in a busy cycle is punishing wherever you sit. Cultural texture differs more than intensity does: HL is described as a training culture built on technical excellence, collegial but rigorous, while PJT reads as institutional and polished, collegial in the Blackstone mold, with intellectual curiosity prized in interviews and on the desk.

PJT pays like the elite boutique it is. First-year analysts earn a $120K base, a $10K signing bonus, and a $75K-$100K year-end bonus, reaching $205K-$230K all-in. HL analysts start at a $105K base with an $8K signing bonus and a $65K-$95K year-end bonus, for $178K-$208K. The roughly $25K gap is the price the market puts on the tier difference, and it tends to persist in later years as bonus bands widen.

The processes look identical on paper: no HireVue, a first round, then a Superday, wrapped up in 2-3 weeks. Difficulty is not identical. PJT rates very challenging, and restructuring questions show up even for M&A candidates, a direct inheritance from the firm's identity. HL rates challenging with a strong valuation emphasis, and RX-track candidates should expect real distressed technicals.

School lists overlap at Wharton, NYU Stern, and Duke, then split. PJT's list is Ivy-dense: Harvard, Princeton, Columbia, Yale, and Dartmouth alongside the overlap schools. HL recruits more broadly, with USC, UCLA, Georgetown, Michigan, and Cornell in the mix, and its 100-120 seat class means more offers exist in absolute terms than at PJT, which takes 50-70 analysts on a 2-3% acceptance rate.

Exits are excellent from both and better from PJT, which scores 5 out of 5 to HL's 4. PJT analysts reach mega-fund private equity and distressed funds; HL analysts land distressed and credit seats plus strong middle-market PE outcomes.